<DOC>
	<DOCNO>NCT01194375</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy IDP-107 versus placebo treat patient acne vulgaris .</brief_summary>
	<brief_title>A Dose-Ranging Study Evaluating Safety Efficacy IDP-107 Patients With Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Presence acne vulgaris face neck/trunk Presence inflammatory noninflammatory lesion face Presence skin condition face could interfere clinical evaluation Use systemic antibiotic corticosteroid within 4 week prior Baseline visit Use systemic retinoids , isotretinoin , within 3 month prior Baseline visit Woman pregnant , nurse infant , plan pregnancy study period</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>